PATENT CLAIM ANALYSIS

Application Number: 16123051
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-06
Patent Classification: ["548", "536000"]

Abstract:
The invention provides trifluoromethyl pyrazolyl guanidine compounds that inhibit F 1 F 0 -ATPase, and methods of using trifluoromethyl pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.

Claim (Index 60):
The method of  claim 57 , wherein the compound that is crystalline has an X-ray powder diffraction pattern substantially as shown in  FIG. 5 .

Metadata:
- Claim Count in Document: 59.0
- Percentile: 97.0
- Lexical Diversity: 1.26471
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14565463', '15015403', '15631380', '12695331', '13156070']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7794674758576282
- 35 USC 102 Novelty (BERT): 0.6070974630764765
- Combined Prediction Score: 0.7622304745795131
- Mean Citation Score: 471.33451
- Max Citation Score: 598.8996599999998
- Similarity Product: 446.9309260059176

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test